$114.99
0.580.51%
Last update: Nov 9, 11:41 AM
Insmed Inc (INSM) Stock Price, Quote, News & History
INSMNASDAQ
Analysts downgraded UWMC, ACT, ROIV, INSM; ACT’s target fell to $44.
You can purchase shares of Insmed (NASDAQ:INSM) through any online brokerage.
Other companies in Insmed’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Insmed has a consensus price target of $196.96.
The stock price for Insmed (NASDAQ: INSM) is $114.99 last updated November 9, 2026 at 11:41 AM EST.
There are no upcoming dividends for Insmed.
Insmed does not have any upcoming earnings scheduled.
There is no upcoming split for Insmed.
Insmed is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Insmed Inc is a biopharmaceutical company. Its commercial portfolio and clinical pipeline are organized around three therapeutic areas: Respiratory, Immunology and Inflammation, and Neuro and Other Rare. The company's two commercial products,...
